Equities

Owlet Inc

OWLT:NYQ

Owlet Inc

Actions
Consumer DiscretionaryHousehold Goods and Home Construction
  • Price (USD)4.39
  • Today's Change0.355 / 8.81%
  • Shares traded8.58k
  • 1 Year change-10.51%
  • Beta1.5564
Data delayed at least 15 minutes, as of Jul 26 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Owlet, Inc. operates as a digital parenting platform company. The Company's platform focuses on giving real-time data and insights to parents. Its products include Owlet Dream Sock, an app to assist children with better sleep; Owlet Cam, a video streaming app to hear and see the baby from anywhere, and Owlet Monitor Duo. The Company offers sock monitor offerings, which include Smart Sock and Dream Sock and Dream Sock Plus. Its Cam offerings include Cam 1 and Cam 2. Its Monitor Duo and Dream Duo offer Sock Monitor offerings paired with the Owlet Cam offerings, combining the intelligence of its Sock Monitor offerings with high-definition video, offering parents the most complete picture of their baby’s sleep. Its accessories product line includes the Owlet Sleeper, a wearable rayon blanket that encourages safe sleep, best for babies ages three-six months old, and an Owlet Sock Travel Case.

  • Revenue in USD (TTM)58.02m
  • Net income in USD-23.69m
  • Incorporated2020
  • Employees76.00
  • Location
    Owlet Inc3300 North Ashton Boulevard, Suite 300LEHI 84043United StatesUSA
  • Phone+1 (424) 208-8488
  • Fax+1 (302) 636-5454
  • Websitehttps://investors.owletcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Retractable Technologies Inc40.20m-7.80m33.83m148.00--0.3402--0.8416-0.2607-0.26071.343.330.21751.545.85271,589.10-4.1012.45-4.3014.5120.2540.82-18.8418.098.18-2.900.0145---54.025.55-249.46--17.42--
iCAD Inc17.94m-5.14m33.97m67.00--1.04--1.89-0.1982-0.08940.69151.230.40810.91992.47267,731.30-11.70-23.94-14.93-34.1485.6076.96-28.66-45.024.59--0.00---12.54-7.5329.32--23.88--
Co-Diagnostics Inc6.68m-38.89m35.74m155.00--0.4471--5.35-1.32-1.320.22682.510.06561.144.2643,083.48-38.195.77-39.936.1541.3482.24-582.3610.949.90--0.000.00-80.09179.54-148.15--101.27--
BioRegenx Inc634.81k-727.95k35.87m10.00--2.11--56.50-0.001-0.0010.00160.01780.0617----63,481.00-7.07---8.46--74.90---114.67--0.1547-8.800.0977---47.25---629.37------
DarioHealth Corp19.04m-59.90m36.21m276.00--0.4565--1.90-2.04-2.040.6332.650.15552.343.5769,000.00-43.90-73.26-51.33-87.5927.5629.54-282.38-293.542.67--0.2673---26.4122.450.5091--52.42--
Icecure Medical Ltd3.26m-14.49m36.56m71.00--3.14--11.21-0.3157-0.31570.0710.24270.1520.79921.7545,943.66-67.52-54.89-84.42-68.6638.2949.87-444.30-313.192.88--0.00--4.6723.5013.70--48.10--
SeaStar Medical Holding Corp0.00-33.67m36.69m12.00---------26.64-26.640.00-1.480.00----0.00-605.20-----------------4.39---------115.19------
Movano Inc852.00k-27.91m37.73m30.00------44.29-0.5593-0.55930.0168-0.02630.0779--2.1228,400.00-254.99-151.50-559.26-188.58-42.61---3,275.47--0.5147----------3.45--4.24--
Precision Optics Corporation Inc19.41m-1.64m38.54m84.00--3.42--1.99-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
electroCore, Inc.18.69m-16.47m38.87m68.00--8.06--2.08-2.85-2.853.130.74861.161.3054.34274,897.10-102.35-70.73-177.94-88.9682.7075.81-88.12-352.821.18--0.00--86.5774.4215.02---5.88--
Owlet Inc58.02m-23.69m39.90m76.00------0.6877-2.87-2.876.71-2.421.062.944.30763,473.70-32.36---181.41--43.05---30.61--0.8182-43.37-----21.95--52.74------
Envoy Medical Inc297.00k-22.43m41.94m34.00------141.23-2.21-2.210.0194-0.37820.04940.47372.368,735.29-381.38---2,885.46---118.18---7,718.86--0.8969-16.54----33.33---87.83------
BioNano Genomics Inc37.47m-226.79m43.41m344.00--0.4359--1.16-6.15-6.150.9421.440.16651.034.97108,924.40-100.76-56.82-128.31-67.8327.5425.38-605.26-505.761.13-83.420.0444--29.9024.65-75.34--38.51--
United Health Products Inc0.00-1.93m45.25m6.00---------0.008-0.0080.00-0.00730.000.00--0.00-719.43-6,446.86------53.19---132,561.200.0483-15.60-----100.00---55.45------
Lucid Diagnostics Inc2.98m-54.53m45.79m70.00------15.35-1.27-1.270.06980.25440.0735--78.5042,614.29-115.88---248.82---111.06---1,576.63--1.36--0.5579--544.03--6.24------
Data as of Jul 26 2024. Currency figures normalised to Owlet Inc's reporting currency: US Dollar USD

Institutional shareholders

6.07%Per cent of shares held by top holders
HolderShares% Held
Cresset Asset Management LLCas of 31 Mar 2024185.22k2.05%
The Vanguard Group, Inc.as of 31 Mar 2024120.08k1.33%
BlackRock Fund Advisorsas of 31 Mar 202462.90k0.70%
Dynamic Advisor Solutions LLCas of 30 Jun 202444.65k0.49%
Geode Capital Management LLCas of 31 Mar 202440.27k0.45%
Insigneo Advisory Services LLCas of 31 Mar 202439.00k0.43%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202418.78k0.21%
SSgA Funds Management, Inc.as of 31 Mar 202416.95k0.19%
HRT Financial LLCas of 31 Mar 202411.82k0.13%
Northern Trust Global Investments Ltd.as of 31 Mar 20249.72k0.11%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.